km.idaeo.ai · IDAEO 知識庫

🏛 Part of the "reports" topic shelf →

Can Bone Graft Material Cause Lasting Problems? What If It Fails?｜證據鏈

km 編輯部2026-08-13About 8 min read
#證據鏈#牙醫KM#台灣#補骨

本頁是〈Can Bone Graft Material Cause Lasting Problems? What If It Fails?〉的事實單元帳：每一條主張對應的來源、證據等級、地域與期間、原文引句與限制，逐條攤開。

Can Bone Graft Material Cause Lasting Problems? What If It Fails?｜證據鏈

F-Units (fact-unit ledger)

  • F1｜confidence: verified｜basis: peer-reviewed (PMID 28938030)｜period: searched to 2015-07; published 2018｜geo: universal｜span: 「The weighted complication rate of the overall soft tissue complications … was 16.8% (95% CI = 10.6% to 25.4%)」「soft tissue lesions were reported as early as 1 week and as late as 6 months」｜caveat: weighted rate of GBR soft-tissue complications, not an individual risk
  • F2｜confidence: verified｜basis: peer-reviewed (PMID 35048503)｜period: searched to 2020-11; published 2022｜geo: universal｜span: 「incidence proportion of healing complications … 11.0%」「membrane exposure without suppuration, membrane exposure with suppuration, and with abscess formation … 8.7% … 0.7% … 0.5%」「RoM of vertical bone gained was 0.65 … and 0.62」「The RoM of vertical bone gained was 0.65 [95% CI = 0.47, 0.91] and 0.62 [95% CI = 0.45, 0.85] when membrane exposure without suppuration and abscess formation without membrane exposure occurred respectively, in comparison to uneventful healing.」「The site-level incidence proportion of membrane exposure without suppuration, membrane exposure with suppuration, and with abscess formation without membrane exposure was 8.7% [95% CI = 4.2, 14.2], 0.7% [95% CI = 0.0, 2.9], and 0.5% [95% CI = 0.0, 1.7], respectively.」｜caveat: limited to vertical GBR; site level
  • F3｜confidence: verified｜basis: peer-reviewed (PMID 30667522)｜period: published 2019｜geo: universal｜span: 「complications rate of 47.3% for distraction osteogenesis, 4.18 mm and 12.1% for guided bone regeneration (GBR), and 3.46 mm and 23.9% for bone blocks」「although complications are common」｜caveat: vertical bone-augmentation setting
  • F4｜confidence: verified｜basis: peer-reviewed (PMID 35737681)｜period: searched 1960-01 to 2021-06｜geo: universal｜span: 「Postoperative pain, swelling, and edema were widely reported」「sinus membrane perforation (SMP), wound dehiscence, graft exposure and failure, and sinusitis」「benign paroxysmal positional vertigo following TSFE was significant in certain selected studies」｜caveat: 74 studies; 4,411 maxillary sinus-elevation cases
  • F5｜confidence: verified｜basis: peer-reviewed (PMID 34250560)｜period: literature from 2008 to 2020-04｜geo: universal｜span: 「survival rate of 97.68% … 98.88%」「The rate of Schneiderian membrane perforation … was 30.6%」「is not a risk factor for dental implant survival (p=0.229; …)」「A total of 1115 implants were placed under previously perforated and repaired membranes, obtaining a survival rate of 97.68%, while 2495 implants were placed below sinus membranes that were not damaged during surgery, obtaining a survival rate of 98.88%.」｜caveat: limited to the lateral-window technique and after repair
  • F6｜confidence: verified｜basis: peer-reviewed (PMID 37752820)｜period: published 2023｜geo: universal｜span: 「regeneration occurred in a predictable way」「several complications (including exposure, infection, and soft tissue dehiscence) were reported, which tend to be higher when using cross-linked collagen membranes」｜caveat: network meta-analysis, limited to GBR with simultaneous implant placement
  • F7｜confidence: verified｜basis: peer-reviewed (PMID 29231263)｜period: published 2018｜geo: universal｜span: 「moderate limitation in the 1st 48 hr post-surgery but little or none by day 3 or 4」「Mild to moderate pain and interference to daily activities were reported for the first 3 days requiring the use of NSAIDs only」「mild to moderate pain and restrictions to daily activities for 48-72 hr」「morbidity were greater with autogenous bone harvesting」｜caveat: prospective controlled trial in 60 people, lateral-window maxillary-sinus procedure; substantial individual variation
  • F8｜confidence: verified｜basis: peer-reviewed (PMID 35056347)｜period: published 2021; 292 studies included｜geo: universal｜span: 「implants in smokers had a higher failure risk in comparison with non-smokers (OR 2.402, p < 0.001)」「MBL mean difference (MD) between the groups was 0.580 mm」｜caveat: combined observational evidence, not causal inference
  • F9｜confidence: verified｜basis: peer-reviewed (PMID 28332067)｜period: published 2017｜geo: universal｜span: 「Postoperative infection and implant loss occurred in 8/121 sinuses (6.6%)」「Infection had the strongest correlation to preoperative chronic sinusitis (p = 0.007)」｜caveat: single-center retrospective study, 109 people
  • F10｜confidence: verified｜basis: peer-reviewed (PMID 36807599)｜period: searched to 2022-08｜geo: universal｜span: 「diabetic patients with dental implants and good glycaemic control have a significantly lower risk of peri-implantitis (odds ratio [OR] = 0.16」「risk of dental implant failure (or = 3.76; 95% ci: 1.50-9.45; …) appears to be greater under irregular or no SPC」｜caveat: indirect evidence; the authors noted evidence limitations
  • F11｜confidence: verified｜basis: clinical guideline (PMID 35300956; AAOMS 2022 position paper)｜period: updated edition 2022｜geo: universal｜span: 「Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaws (MRONJ)」｜caveat: this card cites only its existence and applicable population, not individual management recommendations
  • F12｜confidence: verified｜basis: peer-reviewed (PMID 35472121)｜period: published 2022｜geo: universal｜span: 「a protocol specific to the classification and management of d-PTFE membrane healing complications is required and is thus presented in this paper」｜caveat: limited to d-PTFE membrane; supports that exposure needs professional classification and management, not self-management
  • F13｜confidence: verified｜basis: peer-reviewed (PMID 37109671)｜period: published 2023; 12 RCTs｜geo: universal｜span: 「The routine use of prophylactic antibiotics to prevent infection in dental implant placement was found to be not sufficiently effective to justify routine use」「Clear clinical assessment pathways … are required」｜caveat: clinical-decision level; patients must not stop medicine on their own on this basis
  • F14｜confidence: verified｜basis: peer-reviewed (PMID 30155575)｜period: published 2019｜geo: universal｜span: 「The interruption of antithrombotics prior to tooth removal because of the fear of bleeding or following postoperative bleeding increases the risk of thromboembolic events」「The investigated haemostatics included gauze pressure」｜caveat: original study context was tooth removal; this card cites only the category of hemostatic measure and risk from stopping medication
  • F15｜confidence: verified｜basis: peer-reviewed (PMID 34074573)｜period: nationwide registry from 1997 to 2013; published 2022｜geo: universal｜span: 「other implant-related complications (infection, implant malposition, lack of bone at implant site, mechanical damage, or failed osseointegration)」｜caveat: Finnish compensation registry data, used only to establish that nerve injury is a known complication category
  • F16｜confidence: verified (rechecked 2026-08-05; same #9 card anchor C2)｜basis: law｜period: current provision｜geo: TW｜span: 《全民健康保險法》第 51 條「十一、義齒、義眼、眼鏡、助聽器、輪椅、拐杖及其他非具積極治療性之裝具。」｜caveat: individual coverage is subject to applicable National Health Insurance terms and current National Health Insurance Administration notices; this card makes no coverage determination
  • F17｜confidence: verified (2026-08-05)｜basis: law｜period: current provision｜geo: TW｜span: 《醫療法》第 63 條「醫療機構實施手術，應向病人或其法定代理人、配偶、親屬或關係人說明手術原因、手術成功率或可能發生之併發症及危險，並經其同意，簽具手術同意書及麻醉同意書，始得為之。」｜caveat: statutory quotation, not legal advice
  • F18｜confidence: verified (2026-08-05)｜basis: law｜period: current provision｜geo: TW｜span: 《醫療法》第 81 條「醫療機構診治病人時，應向病人或其法定代理人、配偶、親屬或關係人告知其病情、治療方針、處置、用藥、預後情形及可能之不良反應。」｜caveat: statutory quotation, not legal advice
  • F19｜confidence: verified (2026-08-05)｜basis: official statement｜period: current dataset status｜geo: TW｜span: 政府資料開放平臺資料集「臺北市醫療收費標準」，提供機關臺北市政府衛生局｜caveat: example from a single municipality; pages for other municipalities must be individually reverified before scale-up; same #9 card anchor C3 family
  • F20｜confidence: verified (entry accessible; rechecked HTTP 200 on 2026-08-05)｜basis: official statement｜period: current entry status｜geo: TW｜span: 健保署醫材比價網入口 info.nhi.gov.tw/INAE2000/INAE2010S01｜caveat: page content loads dynamically in JS and cannot be compared verbatim with curl; name and inclusion scope were checked against #9 card anchor C4; whether bone-graft material is among searchable items requires a further live check before publication; OP’s 2026-08-05 live-test correction: neither of the site’s two category paths includes dentistry, so bone-graft material cannot be verified there
  • F21｜confidence: verified｜basis: internal data｜period: GSC from 2025-03 to 2026-08｜geo: TW｜span: backlog #28「補骨粉後遺症」等 7 詞項合計曝光 121,073，跨 4 站｜caveat: impressions are an attribute-level number, not deduplicated traffic
  • F22｜confidence: structural synthesis (editorial framework, not an external factual claim)｜basis: editorial framework｜period: 2026-08-05｜geo: universal｜span: 「文獻中廣泛報告的反應／該安排回診／該盡快就醫」三級分辨框架與「一天比一天輕」的走勢判斷，為本站依 F1 至 F15 文獻整理的溝通用架構｜caveat: not a diagnostic tool and does not replace clinical judgment

Sources

取用日期均為 2026-08-05；PubMed 條目以 E-utilities efetch 取得摘要原文，並逐條實測條目頁回應 200。

  1. Lim G, et al. Wound Healing Complications Following Guided Bone Regeneration for Ridge Augmentation: A Systematic Review and Meta-Analysis. Int J Oral Maxillofac Implants. 2018;33(1):41-50. PMID 28938030
  2. Tay JRH, et al. Healing complications and their detrimental effects on bone gain in vertical-guided bone regeneration: A systematic review and meta-analysis. Clin Implant Dent Relat Res. 2022;24(1):43-71. PMID 35048503
  3. Urban IA, et al. Effectiveness of vertical ridge augmentation interventions: A systematic review and meta-analysis. J Clin Periodontol. 2019;46 Suppl 21:319-339. PMID 30667522
  4. Hsu YT, et al. Complications of sinus floor elevation procedure and management strategies: A systematic review. Clin Implant Dent Relat Res. 2022;24(6):740-765. PMID 35737681
  5. Díaz-Olivares LA, et al. Management of Schneiderian membrane perforations during maxillary sinus floor augmentation with lateral approach in relation to subsequent implant survival rates: a systematic review and meta-analysis. Int J Implant Dent. 2021;7(1):91. PMID 34250560
  6. Calciolari E, et al. Efficacy of biomaterials for lateral bone augmentation performed with guided bone regeneration. A network meta-analysis. Periodontol 2000. 2023;93(1):77-106. PMID 37752820
  7. Alayan J, Ivanovski S. A prospective controlled trial comparing xenograft/autogenous bone and collagen-stabilized xenograft for maxillary sinus augmentation. Clin Oral Implants Res. 2018;29(2):248-262. PMID 29231263
  8. Mustapha AD, et al. Smoking and Dental Implants: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2021;58(1):39. PMID 35056347
  9. Kozuma A, et al. Preoperative chronic sinusitis as significant cause of postoperative infection and implant loss after sinus augmentation from a lateral approach. Oral Maxillofac Surg. 2017;21(2):193-200. PMID 28332067
  10. Carra MC, et al. Primordial and primary prevention of peri-implant diseases: A systematic review and meta-analysis. J Clin Periodontol. 2023;50 Suppl 26:77-112. PMID 36807599
  11. Ruggiero SL, et al. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update. J Oral Maxillofac Surg. 2022;80(5):920-943. PMID 35300956
  12. Vroom MG, et al. Clinical Classification of Healing Complications and Management in Guided Bone Regeneration Procedures with a Nonresorbable d-PTFE Membrane. Int J Periodontics Restorative Dent. 2022;42(3):419-427. PMID 35472121
  13. Torof E, et al. Antibiotic Use in Dental Implant Procedures: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2023;59(4):713. PMID 37109671
  14. Ockerman A, et al. Local haemostatic measures after tooth removal in patients on antithrombotic therapy: a systematic review. Clin Oral Investig. 2019;23(4):1695-1708. PMID 30155575
  15. Pääsky E, et al. Are women more susceptible than men to iatrogenic inferior alveolar nerve injury in dental implant surgery? Int J Oral Maxillofac Surg. 2022;51(2):251-256. PMID 34074573
  16. 全民健康保險法 第 51 條（全國法規資料庫）
  17. 醫療法 第 63 條（全國法規資料庫）
  18. 醫療法 第 81 條（全國法規資料庫）
  19. 政府資料開放平臺：臺北市醫療收費標準（提供機關：臺北市政府衛生局）
  20. 衛生福利部中央健康保險署 醫材比價網（入口）
  21. 內部數據：`analysis/reports/km-dental-backlog.md` #28 附錄（詞×站×曝光逐筆可對帳）
  22. 編輯框架：本站三級分辨結構（無外部來源，標示為結構性整理）

Internal citation chain

  • How to ask about costs and read a quotation: How Much Does One Dental Implant Really Cost? (KM-DENTAL-09)
  • “Dental cap” terminology triage and cost components: How Much Does a “Dental Cap” Cost? (KM-DENTAL-08)
Publication-gate reminder: this card is a draft. It must not enter km_entries until the three translated versions (zh-Hans / en / ja) have been produced. Until the range of bone-graft-material items included in F20 has been live-tested, that statement remains a route for verification and must not be rewritten as a price statement.

FAQ

When do I need prompt medical care rather than wait?
Pus or an abscess, clear signs of infection, swelling or pain that is not easing and instead is getting worse, bleeding that continues or remains difficult to control after pressure, or persistent numbness of the lip, chin, or tongue all warrant prompt medical care [F2][F6][F7][F22][F14][F15].
どんな時は速やかに受診すべきですか？ — 排膿または膿瘍の形成、明らかな感染徴候、腫れや痛みが軽くならずむしろ悪化すること、出血が続くか圧迫しても止まりにくいこと、または唇・あご・舌のしびれが続くときは、速やかに受診してください [F2][F6][F7][F22][F14][F15]。
When do I need prompt medical care rather than wait? — Pus or an abscess, clear signs of infection, swelling or pain that is not easing and instead is getting worse, bleeding that continues or remains difficult to control after pressure, or persistent numbness of the lip, chin, or tongue all warrant prompt medical care [F2][F6][F7][F22][F14][F15].
Does graft material “coming out” mean it has failed?
**Not necessarily.** Exposed particles are often related to wound dehiscence or barrier-membrane exposure. A systematic review lists graft exposure as a complication that may need intervention [F4], and membrane exposure has specific classification and management pathways that a clinician judges according to the material and extent [F12]. The literature shows that complications reduce bone gain (mean ratios 0.65 and 0.62) [F2], but that is different from saying the whole course of treatment has been voided. Return for an assessment; do not remove exposed material yourself.
骨補填材が「出てきた」ことは失敗を意味しますか？ — **必ずしもそうではありません。** 粒子の露出は、創部離開またはバリア膜露出に関連することが多いです。系統的レビューでは、移植材料の露出を介入処置が必要になり得る合併症の一つに挙げ [F4]、膜露出には材料と程度に応じて医師が判断する専用の分類・処置の流れがあります [F12]。文献は、合併症により骨増量が減少すること（平均比 0.65 と 0.62）を示しています [F2]。ただし、これは治療全体が無効になることとは別です。受診して評価を受け、露出物を自分で取り除かないでください。
Does graft material “coming out” mean it has failed? — **Not necessarily.** Exposed particles are often related to wound dehiscence or barrier-membrane exposure. A systematic review lists graft exposure as a complication that may need intervention [F4], and membrane exposure has specific classification and management pathways that a clinician judges according to the material and extent [F12]. The literature shows that complications reduce bone gain (mean ratios 0.65 and 0.62) [F2], but that is different from saying the whole course of treatment has been voided. Return for an assessment; do not remove exposed material yourself.
How long will the swelling take to go away?
**In the general timeline described in the literature, it is more noticeable during the first 48 hours, and by postoperative day 3 or 4 it is little or no impact for most people.** The prospective controlled trial recorded mild-to-moderate pain and limitation of daily activities for 48 to 72 hours after surgery [F7]. Actual recovery speed varies by person and requires a dentist’s assessment.
腫れはどのくらいで引きますか？ — **文献が述べる一般的な経過では、最初の 48 時間がより目立ち、術後 3〜4 日には多くの人で軽微または影響なしになります。** 前向き対照試験が記録したのは、術後 48〜72 時間の軽度から中等度の痛みと日常活動制限です [F7]。実際の回復速度は人により異なり、歯科医師の評価が必要です。
How long will the swelling take to go away? — **In the general timeline described in the literature, it is more noticeable during the first 48 hours, and by postoperative day 3 or 4 it is little or no impact for most people.** The prospective controlled trial recorded mild-to-moderate pain and limitation of daily activities for 48 to 72 hours after surgery [F7]. Actual recovery speed varies by person and requires a dentist’s assessment.

Source anchors

Cite this article

km 編輯部・《Can Bone Graft Material Cause Lasting Problems? What If It Fails?｜證據鏈》・IDAEO 知識庫・2026-08-13・https://km.idaeo.ai/post/reports/dental-bone-graft-complications-evidence

Related articles

更新 2026-08-13T14:17:05.115Z · server-rendered · four-language · IDAEO 知識庫